肥胖症治疗药物。
Medicines for the Treatment of Obesity.
机构信息
Department of Formula Sciences, College of Korean Medicine, Dongeui University, Busan 47227, Korea.
Department of Biomedical Engineering, Mokwon University, Daejeon 35349, Korea.
出版信息
Int J Mol Sci. 2021 Apr 8;22(8):3866. doi: 10.3390/ijms22083866.
Abstract
Obesity is the result of an energy imbalance caused by an increased ratio of caloric intake to energy expenditure [...].
摘要
肥胖是由热量摄入与能量消耗的比例增加导致的能量失衡引起的[... ]。
相似文献
1
Medicines for the Treatment of Obesity.肥胖症治疗药物。
Int J Mol Sci. 2021 Apr 8;22(8):3866. doi: 10.3390/ijms22083866.
2
[Energy metabolism in obese children].[肥胖儿童的能量代谢]
Ann Pediatr (Paris). 1993 May;40(5):291-6.
3
Effect of physical exercise on spontaneous physical activity energy expenditure and energy intake in overweight adults (the EFECT study): a study protocol for a randomized controlled trial.体育锻炼对超重成年人自发身体活动能量消耗和能量摄入的影响（EFECT研究）：一项随机对照试验的研究方案
Trials. 2018 Mar 7;19(1):167. doi: 10.1186/s13063-018-2445-6.
4
Beiging of white adipose tissue as a therapeutic strategy for weight loss in humans.白色脂肪组织褐变作为人类减肥的一种治疗策略。
Horm Mol Biol Clin Investig. 2017 Jun 23;31(2):/j/hmbci.2017.31.issue-2/hmbci-2017-0016/hmbci-2017-0016.xml. doi: 10.1515/hmbci-2017-0016.
5
Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity.治疗性激活人体能量消耗和产热以治疗肥胖的机遇与挑战。
J Biol Chem. 2020 Feb 14;295(7):1926-1942. doi: 10.1074/jbc.REV119.007363. Epub 2019 Dec 30.
6
Obesity: determinants and therapeutic initiatives.肥胖：决定因素与治疗措施
Nutrition. 1991 Jul-Aug;7(4):292-4.
7
[Energy expenditure and obesity].[能量消耗与肥胖]
Rev Med Brux. 1994 Jul-Aug;15(4):255-8.
8
Association of energy intake and expenditure with obesity: A cross-sectional study of 150 pediatric patients following treatment for leukemia.能量摄入与消耗与肥胖的关联：一项对150名白血病治疗后儿科患者的横断面研究。
Pediatr Hematol Oncol. 2017 Feb;34(1):29-35. doi: 10.1080/08880018.2016.1272025. Epub 2017 Mar 13.
9
Cellular, metabolic, and clinical consequences of adipose mass enlargement in obesity.肥胖中脂肪量增加的细胞、代谢及临床后果。
Nutrition. 1991 Jul-Aug;7(4):287-9.
10
Proactive and Progressive Approaches in Managing Obesity.管理肥胖症的积极主动和循序渐进的方法。
Postgrad Med. 2016 Oct;128 Suppl 1:21-30. doi: 10.1080/00325481.2016.1181412. Epub 2016 May 6.
引用本文的文献
1
The combination of nuclear receptor NR1D1 and ULK1 promotes mitophagy in adipocytes to ameliorate obesity.核受体 NR1D1 和 ULK1 的结合促进脂肪细胞中的自噬作用，从而改善肥胖。
Adipocyte. 2022 Dec;11(1):202-212. doi: 10.1080/21623945.2022.2060719.
本文引用的文献
1
Current Evidence to Propose Different Food Supplements for Weight Loss: A Comprehensive Review.提出不同减肥食品补充剂的当前证据：综合评价。
Nutrients. 2020 Sep 20;12(9):2873. doi: 10.3390/nu12092873.
2
Induction of Adipose Tissue Browning as a Strategy to Combat Obesity.诱导脂肪组织棕色化作为对抗肥胖的策略。
Int J Mol Sci. 2020 Aug 28;21(17):6241. doi: 10.3390/ijms21176241.
3
Lemon Balm Extract ALS-L1023 Regulates Obesity and Improves Insulin Sensitivity via Activation of Hepatic PPARα in High-Fat Diet-Fed Obese C57BL/6J Mice.柠檬香蜂草提取物 ALS-L1023 通过激活高脂饮食喂养的肥胖 C57BL/6J 小鼠肝脏中的 PPARα 来调节肥胖和改善胰岛素敏感性。
Int J Mol Sci. 2020 Jun 15;21(12):4256. doi: 10.3390/ijms21124256.
4
Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis.白细胞介素-8 循环水平与病态肥胖和非酒精性脂肪性肝炎妇女肝组织中 TLR2 表达的关系。
Int J Mol Sci. 2020 Jun 11;21(11):4189. doi: 10.3390/ijms21114189.
5
Gomisin N from Ameliorates Lipid Accumulation and Induces a Brown Fat-Like Phenotype through AMP-Activated Protein Kinase in 3T3-L1 Adipocytes.五味子甲素通过激活 3T3-L1 脂肪细胞中的 AMP 激活蛋白激酶改善脂质积累并诱导产热棕色脂肪样表型。
Int J Mol Sci. 2020 Mar 20;21(6):2153. doi: 10.3390/ijms21062153.
6
Ergosterol Peroxide from the Medicinal Mushroom Inhibits Differentiation and Lipid Accumulation of 3T3-L1 Adipocytes.药用真菌麦角甾醇过氧化物抑制 3T3-L1 脂肪细胞的分化和脂质积累。
Int J Mol Sci. 2020 Jan 10;21(2):460. doi: 10.3390/ijms21020460.
7
Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.肥胖治疗的药理学演变：关注不良反应特征。
Diabetes Obes Metab. 2016 Jun;18(6):558-70. doi: 10.1111/dom.12657.
8
Medical therapy for the patient with obesity.肥胖患者的医学治疗。
Circulation. 2012 Apr 3;125(13):1695-703. doi: 10.1161/CIRCULATIONAHA.111.026567.
9
Central and peripheral molecular targets for antiobesity pharmacotherapy.抗肥胖症药物治疗的中枢和外周分子靶点。
Clin Pharmacol Ther. 2010 Jun;87(6):652-62. doi: 10.1038/clpt.2010.57. Epub 2010 May 5.
10
Abdominal obesity and metabolic syndrome.腹部肥胖与代谢综合征。
Nature. 2006 Dec 14;444(7121):881-7. doi: 10.1038/nature05488.
Zotero 插件